Maximilian Lennartz

1.8k total citations
23 papers, 59 citations indexed

About

Maximilian Lennartz is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maximilian Lennartz has authored 23 papers receiving a total of 59 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maximilian Lennartz's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Maximilian Lennartz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Maximilian Lennartz collaborates with scholars based in Germany, Switzerland and United States. Maximilian Lennartz's co-authors include Jan‐Peter Sperhake, Dominik Nörz, Marc Lütgehetmann, Markus Glatzel, Axel Heinemann, Klaus Püschel, Fabian Heinrich, Herbert Mushumba, Guido Sauter and Christian Bernreuther and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Maximilian Lennartz

21 papers receiving 57 citations

Peers

Maximilian Lennartz

ONCOL

DERMA

PRM

Sabrina Herrera Colombia

Vidhya Murthy United Kingdom

Fanny Lassalle France

Hilary Racher Canada

Fanny Pommeret France

Cristina Castillo Spain

Silvia Monsalvo Spain

Haiming Kou China

Ryusuke Anan Japan

Ruidi Yu China

Sabrina Herrera Colombia

Maximilian Lennartz

21 ×0.9

ONCOL

29 ×1.3

20 ×1.7

5 ×0.4

DERMA

8 ×0.7

PRM

Citations per year, relative to Maximilian Lennartz Maximilian Lennartz (= 1×) peers Sabrina Herrera

Countries citing papers authored by Maximilian Lennartz

Since Specialization

Citations

This map shows the geographic impact of Maximilian Lennartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Lennartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Lennartz more than expected).

Fields of papers citing papers by Maximilian Lennartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Lennartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Lennartz. The network helps show where Maximilian Lennartz may publish in the future.

Co-authorship network of co-authors of Maximilian Lennartz

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Lennartz. A scholar is included among the top collaborators of Maximilian Lennartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Lennartz. Maximilian Lennartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gorbokon, Natalia, Maximilian Lennartz, Sarah Minner, et al.. (2025). Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas. Cancers. 17(7). 1205–1205. 2 indexed citations

Gorbokon, Natalia, Maximilian Lennartz, Andreas M. Luebke, et al.. (2024). PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(3). 491–507. 5 indexed citations

Lennartz, Maximilian, et al.. (2023). Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer. Hämostaseologie. 43(4). 289–296. 1 indexed citations

Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). 2355P Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. Annals of Oncology. 34. S1197–S1197. 1 indexed citations

Kluth, Martina, Maximilian Lennartz, Niclas C. Blessin, et al.. (2023). MYC amplifications are a common event in urothelial bladder carcinomas associated with an aggressive tumor phenotype. American Journal of Clinical Pathology. 160(Supplement_1). S91–S92. 1 indexed citations

Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations

Lennartz, Maximilian, Niclas C. Blessin, Claudia Hube‐Magg, et al.. (2023). TRPS1 is a highly sensitive marker for breast cancer: A tissue microarray study evaluating more than 19,000 tumors from 152 different tumor entities. American Journal of Clinical Pathology. 160(Supplement_1). S12–S13. 2 indexed citations

Klatte, Tobias, Sefer Elezkurtaj, Maria De Santis, et al.. (2023). Presence of CD8⁺ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.. Journal of Clinical Oncology. 41(16_suppl). 4582–4582. 1 indexed citations

Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. American Journal of Clinical Pathology. 160(Supplement_1). S36–S36. 1 indexed citations

10.

Möller, Katharina, Natalia Gorbokon, Claudia Hube‐Magg, et al.. (2023). Comparison of INSM1 immunostaining with established neuroendocrine markers Synaptophysin and Chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. American Journal of Clinical Pathology. 160(Supplement_1). S36–S37.

11.

Lennartz, Maximilian, Christian Bernreuther, Franziska Büscheck, et al.. (2022). Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. Urologic Oncology Seminars and Original Investigations. 40(7). 348.e1–348.e8. 1 indexed citations

12.

Bengtsson, Ewert, et al.. (2022). AI-based prostate analysis system trained without human supervision to predict patient outcome from tissue samples. Journal of Pathology Informatics. 13. 100137–100137. 2 indexed citations

13.

Möller, Katharina, Tim Mandelkow, Ronald Simon, et al.. (2022). Abstract 597: BLEACH&STAIN 15 marker multiplexed imaging in 3098 human carcinomas revealed six major PD-L1 driven immune phenotypes with distinct spatial orchestration. Cancer Research. 82(12_Supplement). 597–597. 1 indexed citations

14.

Schmiedel, Stefan, et al.. (2021). Rätselhafte B-Symptomatik bei einem 61-Jährigen unter Therapie einer rheumatoiden Arthritis. Der Internist. 62(11). 1231–1236. 1 indexed citations

15.

Voigtlaender, Minna, Katharina Holstein, Maximilian Lennartz, et al.. (2021). Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome. Research and Practice in Thrombosis and Haemostasis. 5(5). e12559–e12559. 2 indexed citations

16.

Dum, David, Niclas C. Blessin, Tim Mandelkow, et al.. (2021). Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence. American Journal of Clinical Pathology. 156(Supplement_1). S137–S138. 1 indexed citations

17.

Weidemann, Sören, Natalia Gorbokon, Doris Höflmayer, et al.. (2021). Abstract 2833: Mesothelin expression in human tumor types: a tissue microarray study on more than 13,000 tumor samples. Cancer Research. 81(13_Supplement). 2833–2833. 1 indexed citations

18.

Büscheck, Franziska, Christoph Fraune, Martina Kluth, et al.. (2020). A non-diploid DNA status is linked to poor prognosis in renal cell cancer. World Journal of Urology. 39(3). 829–837. 1 indexed citations

19.

Heinrich, Fabian, Jan‐Peter Sperhake, Axel Heinemann, et al.. (2020). Germany’s first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(3). 335–339. 25 indexed citations

20.

Lennartz, Maximilian, Sarah Minner, Martina Kluth, et al.. (2015). The combination of DNA ploidy status and PTEN/6q15 deletions to provide strong and independent prognostic information in prostate cancer.. Journal of Clinical Oncology. 33(15_suppl). 5027–5027. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact